Oxybutynin Chloride Patent Expiration
Oxybutynin Chloride is Used for managing incontinence, hormone replacement therapy, treating involuntary incontinence, managing overactive bladder, and increasing compliance in patients. It was first introduced by Ortho Mcneil Janssen Pharmaceuticals Inc
Oxybutynin Chloride Patents
Given below is the list of patents protecting Oxybutynin Chloride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Gelnique | US8920392 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | Mar 26, 2031 | Abbvie |
Gelnique | US10449173 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | Nov 06, 2029 | Abbvie |
Gelnique | US9259388 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | Nov 06, 2029 | Abbvie |
Gelnique | US10272061 | Compositions and methods for unoccluded transdermal oxybutynin therapy |
Apr 26, 2020
(Expired) | Abbvie |
Gelnique | US7029694 | Compositions and methods for transdermal oxybutynin therapy |
Apr 26, 2020
(Expired) | Abbvie |
Gelnique | US7179483 | Compositions and methods for transdermal oxybutynin therapy |
Apr 26, 2020
(Expired) | Abbvie |
Gelnique | US8241662 | Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy |
Apr 26, 2020
(Expired) | Abbvie |
Ditropan Xl |
US5674895 (Pediatric) | Dosage form comprising oxybutynin |
Nov 22, 2015
(Expired) | Janssen Pharms |
Ditropan Xl |
US5840754 (Pediatric) | Dosage form comprising oxybutynin |
Nov 22, 2015
(Expired) | Janssen Pharms |
Ditropan Xl |
US5912268 (Pediatric) | Dosage form and method for treating incontinence |
Nov 22, 2015
(Expired) | Janssen Pharms |
Ditropan Xl |
US6262115 (Pediatric) | Method for the management of incontinence |
Nov 22, 2015
(Expired) | Janssen Pharms |
Ditropan Xl | US5674895 | Dosage form comprising oxybutynin |
May 22, 2015
(Expired) | Janssen Pharms |
Ditropan Xl | US5840754 | Dosage form comprising oxybutynin |
May 22, 2015
(Expired) | Janssen Pharms |
Ditropan Xl | US5912268 | Dosage form and method for treating incontinence |
May 22, 2015
(Expired) | Janssen Pharms |
Ditropan Xl | US6262115 | Method for the management of incontinence |
May 22, 2015
(Expired) | Janssen Pharms |
Oxybutynin Chloride's Family Patents
Explore Our Curated Drug Screens
Oxybutynin Chloride Generic API Manufacturers
Several generic applications have been filed for Oxybutynin Chloride. The first generic version for Oxybutynin Chloride was by Usl Pharma Inc and was approved on Mar 10, 1988. And the latest generic version is by Rising Pharma Holdings Inc and was approved on Feb 7, 2023.
Given below is the list of companies who have filed for Oxybutynin Chloride generic, along with the locations of their manufacturing plants worldwide.
1. ABHAI LLC
Abhai Llc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Abhai Llc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet | Prescription | ORAL | AB | Dec 22, 2017 |
2. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet, extended release | Prescription | ORAL | AB | Feb 29, 2016 |
15MG
(reference standard) | tablet, extended release | Prescription | ORAL | AB | Feb 29, 2016 |
10MG | tablet, extended release | Prescription | ORAL | AB | Feb 29, 2016 |
3. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet, extended release | Prescription | ORAL | AB | Feb 28, 2019 |
15MG | tablet, extended release | Prescription | ORAL | AB | Feb 28, 2019 |
5MG | tablet, extended release | Prescription | ORAL | AB | Feb 28, 2019 |
Manufacturing Plant Locations New
Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
4. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet, extended release | Prescription | ORAL | AB | Nov 23, 2015 |
10MG | tablet, extended release | Prescription | ORAL | AB | Nov 23, 2015 |
15MG | tablet, extended release | Prescription | ORAL | AB | Nov 23, 2015 |
5. AVET LIFESCIENCES
Avet Lifesciences Ltd has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Avet Lifesciences.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet | Discontinued | ORAL | N/A | May 10, 2019 |
6. BEXIMCO PHARMS USA
Beximco Pharmaceuticals Usa Inc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Beximco Pharms Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet | Prescription | ORAL | AB | Jul 14, 2022 |
7. BIONPHARMA
Bionpharma Inc has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Bionpharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
15MG | tablet, extended release | Prescription | ORAL | AB | Dec 17, 2019 |
5MG | tablet, extended release | Prescription | ORAL | AB | Dec 17, 2019 |
10MG | tablet, extended release | Prescription | ORAL | AB | Dec 17, 2019 |
Manufacturing Plant Locations New
Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
8. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG/5ML | syrup | Prescription | ORAL | AA | Jan 29, 1999 |
10% (100MG/PACKET) | gel | Discontinued | TRANSDERMAL | N/A | May 31, 2018 |
9. HIBROW HLTHCARE
Hibrow Healthcare Private Ltd has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Hibrow Hlthcare.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet | Discontinued | ORAL | N/A | Feb 6, 2019 |
10. IMPAX PHARMS
Impax Pharmaceuticals has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Impax Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
15MG | tablet, extended release | Discontinued | ORAL | N/A | Nov 9, 2006 |
5MG | tablet, extended release | Discontinued | ORAL | N/A | May 9, 2007 |
10MG | tablet, extended release | Discontinued | ORAL | N/A | May 9, 2007 |
11. LANNETT CO INC
Lannett Co Inc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG/5ML | syrup | Discontinued | ORAL | N/A | Dec 28, 2004 |
12. LEADING
Leading Pharma Llc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Leading.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet | Prescription | ORAL | AB | Apr 6, 2020 |
Manufacturing Plant Locations New
Leading's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Leading as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
|
13. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet, extended release | Discontinued | ORAL | N/A | Nov 9, 2006 |
5MG | tablet, extended release | Discontinued | ORAL | N/A | Nov 9, 2006 |
15MG | tablet, extended release | Discontinued | ORAL | N/A | May 10, 2007 |
14. NOVAST LABS
Novast Laboratories Ltd has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Novast Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet | Prescription | ORAL | AB | Oct 30, 2019 |
15. NOVITIUM PHARMA
Novitium Pharma Llc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Novitium Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet | Prescription | ORAL | AB | Oct 23, 2017 |
Manufacturing Plant Locations New
Novitium Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Novitium Pharma as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
16. OSMOTICA PHARM US
Osmotica Pharmaceutical Us Llc has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Osmotica Pharm Us.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet, extended release | Prescription | ORAL | AB | Feb 4, 2009 |
10MG | tablet, extended release | Prescription | ORAL | AB | Feb 4, 2009 |
15MG | tablet, extended release | Prescription | ORAL | AB | Feb 4, 2009 |
17. PHARM ASSOC
Pharmaceutical Associates Inc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Pharm Assoc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG/5ML | syrup | Discontinued | ORAL | N/A | Dec 18, 1998 |
18. PHARMOBEDIENT CNSLTG
Pharmobedient Consulting has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Pharmobedient Cnsltg.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG/5ML | syrup | Discontinued | ORAL | N/A | Feb 12, 1997 |
19. QUANTUM PHARMICS
Quantum Pharmics Ltd has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Quantum Pharmics.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet | Discontinued | ORAL | N/A | Dec 8, 1988 |
20. RISING
Rising Pharma Holdings Inc has filed for 2 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Rising.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet | Prescription | ORAL | AB | Dec 21, 2017 |
2.5MG
(reference standard) | tablet | Prescription | ORAL | N/A | Feb 7, 2023 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
Country | City | Firm Name | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||||
Mexico |
| |||||||||||||||||||
India |
|
21. RUBICON
Rubicon Research Private Ltd has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Rubicon.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
15MG | tablet, extended release | Prescription | ORAL | AB | Oct 27, 2020 |
10MG | tablet, extended release | Prescription | ORAL | AB | Oct 27, 2020 |
5MG | tablet, extended release | Prescription | ORAL | AB | Oct 27, 2020 |
Manufacturing Plant Locations New
Rubicon's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Rubicon as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
| |||||
Canada |
| |||||
India |
|
22. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet | Prescription | ORAL | AB | Dec 17, 2020 |
Manufacturing Plant Locations New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
| |||||
India |
|
23. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet | Prescription | ORAL | AB | Nov 14, 1988 |
24. TRUPHARMA
Trupharma Llc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Trupharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet | Prescription | ORAL | AB | Sep 6, 2018 |
25. UNIQUE
Unique Pharmaceutical Laboratories A Div Of Jb Chemicals And Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Unique.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet, extended release | Prescription | ORAL | AB | May 27, 2016 |
10MG | tablet, extended release | Prescription | ORAL | AB | May 27, 2016 |
15MG | tablet, extended release | Prescription | ORAL | AB | May 27, 2016 |
Manufacturing Plant Locations New
Unique's manufacturing plants are situated in 5 countries - United States, India, Canada, Portugal, Taiwan. Given below are the details of these plant locations as well as the firm names of Unique as present at those locations.
Country | City | Firm Name | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||||||||||||||||
India |
| |||||||||||||||||||||||||||||||
Canada |
| |||||||||||||||||||||||||||||||
Portugal |
| |||||||||||||||||||||||||||||||
Taiwan |
|
26. UPSHER SMITH LABS
Upsher Smith Laboratories Llc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet | Prescription | ORAL | AB | Jul 31, 1996 |
27. USL PHARMA
Usl Pharma Inc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Usl Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet | Discontinued | ORAL | N/A | Mar 10, 1988 |
28. WATSON LABS
Watson Laboratories Inc has filed for 1 generic for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Watson Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet | Discontinued | ORAL | N/A | Apr 19, 1989 |
29. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Oxybutynin Chloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
5MG | tablet, extended release | Prescription | ORAL | AB | Jun 26, 2017 |
10MG | tablet, extended release | Prescription | ORAL | AB | Jun 26, 2017 |
15MG | tablet, extended release | Prescription | ORAL | AB | Jun 26, 2017 |